Stratis Medical, Inc., Establishes an Exclusive Distribution Agreement for the Mirocam Capsule
June 01, 2018 at 06:33 pm IST
Share
Stratis Medical Inc. announced at Digestive Disease Week 2018 that the company has established an exclusive distribution agreement for the MiroCam Capsule Endoscopy System in the United States manufactured by IntroMedic Co., Ltd. There are over four million cases of IBD and IDA in the U.S. alone, and a significant portion of these patients could benefit from an examination of the entire small bowel. MiroCam represents a best-in-class, leading alternative to current VCE technology and adds clinical value to the improvement in increasing diagnostic yield. The MiroCam VCE is intended for visualization and monitoring of the small bowel mucosa such as in suspected Crohn's disease, lesions that may be the source of GI bleed (either overt or occult) and iron deficiency anemia (IDA). MiroCam is the first capsule endoscopy system with E-Field Propagation or Human Body Communication (HBC), a patented technology utilizing the human body as a communication medium. This innovative approach results in high image resolution and longer operating time, enabling more consistent and accurate diagnosis of the entire small bowel.
IntroMedic Co., Ltd. is a Korea-based company mainly engaged in the development, manufacture and distribution of medical equipment. The Companyâs products consist of capsule endoscope, which is used for small intestine check under the brand name MiroCam; disposable endoscope, which is used to detect abnormalities of the esophagus and the stomach under the brand name E.G. Scan, and other accessories, such as abdominal disposable data belts and others. The Company distributes its products within domestic market and to overseas markets.